11-65976832-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005146.5(SART1):c.1857+66C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00704 in 1,381,676 control chromosomes in the GnomAD database, including 562 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.014 ( 79 hom., cov: 33)
Exomes 𝑓: 0.0061 ( 483 hom. )
Consequence
SART1
NM_005146.5 intron
NM_005146.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.223
Publications
2 publications found
Genes affected
SART1 (HGNC:10538): (spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP) This gene encodes two proteins, the SART1(800) protein expressed in the nucleus of the majority of proliferating cells, and the SART1(259) protein expressed in the cytosol of epithelial cancers. The SART1(259) protein is translated by the mechanism of -1 frameshifting during posttranscriptional regulation; its full-length sequence is not published yet. The two encoded proteins are thought to be involved in the regulation of proliferation. Both proteins have tumor-rejection antigens. The SART1(259) protein possesses tumor epitopes capable of inducing HLA-A2402-restricted cytotoxic T lymphocytes in cancer patients. This SART1(259) antigen may be useful in specific immunotherapy for cancer patients and may serve as a paradigmatic tool for the diagnosis and treatment of patients with atopy. The SART1(259) protein is found to be essential for the recruitment of the tri-snRNP to the pre-spliceosome in the spliceosome assembly pathway. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.146 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0143 AC: 2174AN: 152150Hom.: 78 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2174
AN:
152150
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00613 AC: 7542AN: 1229408Hom.: 483 Cov.: 17 AF XY: 0.00595 AC XY: 3646AN XY: 612606 show subpopulations
GnomAD4 exome
AF:
AC:
7542
AN:
1229408
Hom.:
Cov.:
17
AF XY:
AC XY:
3646
AN XY:
612606
show subpopulations
African (AFR)
AF:
AC:
769
AN:
28626
American (AMR)
AF:
AC:
394
AN:
35096
Ashkenazi Jewish (ASJ)
AF:
AC:
44
AN:
22548
East Asian (EAS)
AF:
AC:
5396
AN:
35312
South Asian (SAS)
AF:
AC:
296
AN:
73974
European-Finnish (FIN)
AF:
AC:
0
AN:
47740
Middle Eastern (MID)
AF:
AC:
7
AN:
4032
European-Non Finnish (NFE)
AF:
AC:
96
AN:
929954
Other (OTH)
AF:
AC:
540
AN:
52126
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
402
805
1207
1610
2012
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0143 AC: 2185AN: 152268Hom.: 79 Cov.: 33 AF XY: 0.0159 AC XY: 1185AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
2185
AN:
152268
Hom.:
Cov.:
33
AF XY:
AC XY:
1185
AN XY:
74448
show subpopulations
African (AFR)
AF:
AC:
1043
AN:
41546
American (AMR)
AF:
AC:
252
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
3470
East Asian (EAS)
AF:
AC:
802
AN:
5170
South Asian (SAS)
AF:
AC:
39
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18
AN:
68016
Other (OTH)
AF:
AC:
26
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
105
209
314
418
523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
180
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.